4.7 Article

Response assessment after an inductive CHOP or CHOP-like regimen with or without rituximab in 103 patients with diffuse large B-cell lymphoma: integrating 18fluorodeoxyglucose positron emission tomography to the International Workshop Criteria

Related references

Note: Only part of the references are listed.
Review Radiology, Nuclear Medicine & Medical Imaging

F-18-FDG PET for posttherapy assessment of Hodgkin's disease and aggressive non-Hodgkin's lymphoma: A systematic review

Teruhiko Terasawa et al.

JOURNAL OF NUCLEAR MEDICINE (2008)

Article Radiology, Nuclear Medicine & Medical Imaging

F-18-FDG PET as a routine test for posttherapy assessment of Hodgkin's disease and aggressive non-Hodgkin's lymphoma: Where is the evidence?

Malik E. Juweid

JOURNAL OF NUCLEAR MEDICINE (2008)

Article Radiology, Nuclear Medicine & Medical Imaging

Early 18F-FDG PET for prediction of prognosis in patients with diffuse large B-cell lymphoma:: SUV-based assessment versus visual analysis

Chieh Lin et al.

JOURNAL OF NUCLEAR MEDICINE (2007)

Article Oncology

Revised response criteria for malignant lymphoma

Bruce D. Cheson et al.

JOURNAL OF CLINICAL ONCOLOGY (2007)

Article Medicine, General & Internal

ACVBP versus CHOP plus radiotherapy for localized aggressive lymphoma

F Reyes et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)